In vitro fertilization. In vitro fertilization
Conditions
Interventions
Intervention 1: The control group(1): progestron pessary administration after positive urinary LH kit. Intervention 2: 5000 Iu HCG injection IM state, after presenting endometrial thickness>7 mm and 1
Sponsors
Tehran University of Medical scinces/Vice chancellor for research
Eligibility
Sex/Gender
Female
Age
No minimum to 38 Years
Inclusion criteria
Inclusion criteria: Age below 38 Regular menstrual cycle Normal BMI The previous history of up to two IVF cycle
Exclusion criteria
Exclusion criteria: PCOD History of endometriosis ( grade =3) according to AFS Abnormal uterin FSH =12 Sever male factor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy rate. Timepoint: 6 weeks of pregnancy. Method of measurement: Ultrasonography.;Abortion rate. Timepoint: During 20 weeks of pregnancy. Method of measurement: Ulthrasonography, B-HCG.;Chemical Pregnancy Rate. Timepoint: 2 weeks after embryo transfer. Method of measurement: Blood Pregnancy Test (BHCG). | — |
Secondary
| Measure | Time frame |
|---|---|
| Implantation. Timepoint: Gestational sac in 5 weeks of pregnancy. Method of measurement: ultrasonography.;Ongoing Pregnancy Rate. Timepoint: 12 weeks of gestation. Method of measurement: The rate of pregnancies that continued =12 weeks of gestation.;Endometrial thickness. Timepoint: At regular intervals until the endometrial thickness reaches above 7 mm. Method of measurement: Transvaginal Ultrasound.;No. of embryos transferred. Timepoint: At the time of embryo transfer. Method of measurement: Embryologist's report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaedeh Aref
Tehran University of Medical Sciences
Outcome results
None listed